Advanced search
Publication Cover
Expert Review of Hematology Volume 14, 2021 - Issue 9
Submit an article Journal homepage
2,232
Views
5
CrossRef citations to date
0
Altmetric
Original research

Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma

Yuqin Songa Department of Clinical Oncology, Beijing Cancer Hospital, Beijing, ChinaView further author information
,
Ye Guob Department of Oncology, Shanghai East Hospital, Tongji University, Shanghai, ChinaView further author information
,
Huiqiang Huangc Department of Medicine, Sun-Yat-sen University Cancer Center, Guangzhou, ChinaView further author information
,
Wei Lid Department of Oncology, The First Hospital of Jilin University, Changchun City, ChinaView further author information
,
Xiaoyan Kee Department of Hematology, Peking University Third Hospital, Beijing, ChinaView further author information
,
Jifeng Fengf Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, ChinaView further author information
,
Wei Xug Department of Hematology, Jiangsu Province People’s Hospital, Nanjing, ChinaView further author information
,
Harry Miaoh Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USAView further author information
,
Judith Kinleyh Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USAView further author information
,
Gregory Songh Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USAView further author information
,
Yi Daih Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USAView further author information
,
Hui Wangh Department of Clinical Oncology, Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USAView further author information
&
Jun Zhui Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 867-875 | Received 08 Apr 2021, Accepted 10 Jun 2021, Published online: 24 Aug 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.